125 related articles for article (PubMed ID: 4714551)
21. [Growth hormone, insulin, glucemia and plasmatic free fatty acids after arginine administration (author's transl)].
Portugal-Alvarez J; Enríquez L; Zamarrón A; Vila T; Catalá E; Velasco-Martín A
Rev Esp Fisiol; 1973 Dec; 29(4):289-91. PubMed ID: 4791170
[No Abstract] [Full Text] [Related]
22. Ghrelin secretion is inhibited by glucose load and insulin-induced hypoglycaemia but unaffected by glucagon and arginine in humans.
Broglio F; Gottero C; Prodam F; Destefanis S; Gauna C; Me E; Riganti F; Vivenza D; Rapa A; Martina V; Arvat E; Bona G; van der Lely AJ; Ghigo E
Clin Endocrinol (Oxf); 2004 Oct; 61(4):503-9. PubMed ID: 15473884
[TBL] [Abstract][Full Text] [Related]
23. The different responses of blood amino acids and blood glucose to the administration of insulin to patients with acromegaly.
Zimmermann-Telschow H; Wiegelmann W; Solbach HG; Zimmermann H
Horm Metab Res; 1973 Nov; 5(6):474-5. PubMed ID: 4767005
[No Abstract] [Full Text] [Related]
24. Effect of lipids on growth hormone secretion in humans.
Blackard WG; Hull EW; Lopez A
J Clin Invest; 1971 Jul; 50(7):1439-43. PubMed ID: 5090059
[TBL] [Abstract][Full Text] [Related]
25. Hypolipidemic effects of metformin in hyperprebetalipoproteinemia.
Fedele D; Tiengo A; Nosadini R; Marchiori E; Briani G; Garotti MC; Muggeo M
Diabete Metab; 1976 Sep; 2(3):127-33. PubMed ID: 188698
[TBL] [Abstract][Full Text] [Related]
26. [Plasma levels of insulin, free fatty acids and growth hormone: their relationship with carbohydrate metabolism in thyrotoxicosis].
Ortigosa JL; Argote RM; García G; Cervantes C; Mendoza F; Parra A
Arch Invest Med (Mex); 1975; 6(3):497-504. PubMed ID: 1190941
[No Abstract] [Full Text] [Related]
27. Influence of metformin on arginine-induced glucagon secretion in human diabetes.
Carpentier J; Luyckx AS; Lefebvre PJ
Diabete Metab; 1975 Mar; 1():23-8. PubMed ID: 1234063
[TBL] [Abstract][Full Text] [Related]
28. [Measurement of plasma insulin and growth hormone after oral glucose tolerance test in patients with alcoholic cirrhosis].
Descos L; M'Bendi S; Sassolas G; Audigier JC; Sidiqian N; Faure A; Bizollon CA
Arch Fr Mal App Dig; 1974; 63(1):17-24. PubMed ID: 4441222
[No Abstract] [Full Text] [Related]
29. Dwarfism with elevated levels of plasma growth hormone.
Najjar SS; Khachadurian AK; Ilbawi MN; Blizzard RM
N Engl J Med; 1971 Apr; 284(15):809-12. PubMed ID: 5549802
[No Abstract] [Full Text] [Related]
30. Glucagon, insulin, cortisol, and growth hormone levels following major surgery: their relationship to glucose and free fatty acid elevations.
Göschke H; Bär E; Girard J; Leutenegger A; Niederer W; Oberholzer M; Wolff G
Horm Metab Res; 1978 Nov; 10(6):465-70. PubMed ID: 744565
[TBL] [Abstract][Full Text] [Related]
31. Effect of weight reduction on insulin responsiveness and triglyceride levels in patients with endogenous hypertriglyceridaemia.
De Vries O; Sluiter WJ; Reitsma WD; Doorenbos H
Neth J Med; 1974; 17(4-5):212-19. PubMed ID: 4465727
[No Abstract] [Full Text] [Related]
32. [Effect of glucagon and of the glucose tolerance test on incretion of the somatotrophic hormone in normal subjects. Comparison of results].
Giordano G; Marugo M; Minuto F; Barreca T
Folia Endocrinol; 1971; 24(3):289-97. PubMed ID: 5171731
[No Abstract] [Full Text] [Related]
33. Growth hormone secretion after insulin stimulation in patients with chronic renal failure.
Kokot F; Kuska J
Pol Med J; 1972; 11(6):1439-45. PubMed ID: 4659068
[No Abstract] [Full Text] [Related]
34. Effect of clofibrate on plasma glucose and serum immunoreactive insulin in patients with hyperlipoproteinemia.
Fenderson RW; Sekowski I; Mohan C; Deutsch S; Benjamin F; Samuel P
Am J Clin Nutr; 1974 Jan; 27(1):22-8. PubMed ID: 4809201
[No Abstract] [Full Text] [Related]
35. Subcutaneous adipose tissue and lipids in blood in growth hormone deficiency before and after treatment with human growth hormone.
Bonnet F; Vanderschueren-Lodeweyckx M; Eeckels R; Malvaux P
Pediatr Res; 1974 Sep; 8(9):800-5. PubMed ID: 4370413
[No Abstract] [Full Text] [Related]
36. Chlorpromazine treatment and growth hormone secretory responses in acromegaly.
Dimond RC; Bramer SR; Atkinson RL; Howard WJ; Earll JM
J Clin Endocrinol Metab; 1973 Jun; 36(6):1189-95. PubMed ID: 4706207
[No Abstract] [Full Text] [Related]
37. Long-term treatment of hyperlipidemic patients with clofibrate.
Berkowitz D
JAMA; 1971 Nov; 218(7):1002-5. PubMed ID: 5000568
[No Abstract] [Full Text] [Related]
38. Effects of halofenate on glucose tolerance in patients with hyperlipoproteinemia.
Feldman EB; Gluck FB; Carter AC
J Clin Pharmacol; 1978; 18(5-6):241-8. PubMed ID: 346616
[TBL] [Abstract][Full Text] [Related]
39. Relationship between body composition and insulin and growth hormone responses in obese adolescents.
Schultz RB; Parra A
Diabetes; 1970 Jul; 19(7):492-501. PubMed ID: 5427553
[No Abstract] [Full Text] [Related]
40. Effect of clofibrate on arginine-stimulated glucagon and insulin secretion in man.
Eaton RP; Schade DS
Metabolism; 1974 May; 23(5):445-54. PubMed ID: 4825301
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
